Waverunner
Senior Member
- Messages
- 1,079
Would be interesting to know how good it really works.
Author: Will Vladimir Stoyanov
Abstract: Telomere shortening is thought to play significant role in cellular aging contributing to human aging and longevity. Critical telomere shortening affects different genes, as human genomes vary, which is why the cascades differ, hence the different effects, organ failures and cancers. For years telomere length maintenance has been targeted. Currently telomerase activators and oligomers addition treatments are available to purchase. Variations of telomere shortening occur within same type of tissue, as well as different tissue types, from same and different individuals. Each old tissue is a mix of mainly old cells with short telomeres less than 5KB and some new cells with normal telomeres more than 15KB. To increase ~20% thus significantly the life span of these human skin cells mix, there were many telomere shortening factors considered, including RNA primers and the t-loop deletion factor. Ideal treatment appears to be ~5KB 5'-(TTAGGG)n-3' oligos dose spread over 1 year, or if administered at once it needs additional dose of 5'CCCTAA3', so that they bind inside the nuclei to reach the ~5KB extension at once. All oligos (TTAGGG)1-50 work, so dosage, frequency and cost considerations suggest as much cheaper to use shorter oligos, e.g. where n=15, 10 or even 5. Treatment per year per organ cost much less compare to telomerase activators. Treatment is harmless, so in 10 years treatment can be repeated for another ~20% and if done again another ~20%. Tests have not been testing to increase human skin cells life span for more than 52%, but theoretically it should work for as long as used.
[video=youtube;1Vw5QAmZsiE]http://www.youtube.com/watch?feature=player_embedded&v=1Vw5QAmZsiE[/video]
Here's the full abstract:
http://sites.google.com/site/journal1stoyanov/oligos-maintaining-telomere-length
Author: Will Vladimir Stoyanov
Abstract: Telomere shortening is thought to play significant role in cellular aging contributing to human aging and longevity. Critical telomere shortening affects different genes, as human genomes vary, which is why the cascades differ, hence the different effects, organ failures and cancers. For years telomere length maintenance has been targeted. Currently telomerase activators and oligomers addition treatments are available to purchase. Variations of telomere shortening occur within same type of tissue, as well as different tissue types, from same and different individuals. Each old tissue is a mix of mainly old cells with short telomeres less than 5KB and some new cells with normal telomeres more than 15KB. To increase ~20% thus significantly the life span of these human skin cells mix, there were many telomere shortening factors considered, including RNA primers and the t-loop deletion factor. Ideal treatment appears to be ~5KB 5'-(TTAGGG)n-3' oligos dose spread over 1 year, or if administered at once it needs additional dose of 5'CCCTAA3', so that they bind inside the nuclei to reach the ~5KB extension at once. All oligos (TTAGGG)1-50 work, so dosage, frequency and cost considerations suggest as much cheaper to use shorter oligos, e.g. where n=15, 10 or even 5. Treatment per year per organ cost much less compare to telomerase activators. Treatment is harmless, so in 10 years treatment can be repeated for another ~20% and if done again another ~20%. Tests have not been testing to increase human skin cells life span for more than 52%, but theoretically it should work for as long as used.
[video=youtube;1Vw5QAmZsiE]http://www.youtube.com/watch?feature=player_embedded&v=1Vw5QAmZsiE[/video]
Here's the full abstract:
http://sites.google.com/site/journal1stoyanov/oligos-maintaining-telomere-length